Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017
| Autor: | Graça M. Dores, Paige Marquez, Carmen Ng, Maria Cano, Penina Haber, Silvia Perez-Vilar, John R. Su |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male Vaccine safety medicine.medical_specialty Adolescent Article Young Adult 03 medical and health sciences Adverse Event Reporting System 0302 clinical medicine 030225 pediatrics medicine Humans 030212 general & internal medicine Erythema multiforme Symptom onset Child Smallpox vaccine Erythema Multiforme General Veterinary General Immunology and Microbiology business.industry Vaccination Public Health Environmental and Occupational Health Bayes Theorem Stevens johnson Middle Aged medicine.disease Dermatology United States Toxic epidermal necrolysis stomatognathic diseases Infectious Diseases Child Preschool Stevens-Johnson Syndrome Molecular Medicine Female business |
| Zdroj: | Vaccine |
| ISSN: | 0264-410X |
| Popis: | BACKGROUND: Since the last review of vaccine safety surveillance data for erythema multiforme (EM), Stevens Johnson syndrome (SJS), SJS/TEN, and toxic epidermal necrolysis (TEN) (EM/SJS/TEN), over 37 new vaccines have been introduced in the United States. We sought to describe reported EM/SJS/TEN after vaccines during 1999–2017. METHODS: We identified U.S. reports of EM/SJS/TEN received by the Vaccine Adverse Event Reporting System (VAERS) during 1999–2017. We stratified analysis by condition (EM, SJS, or TEN), and analyzed reports by serious or non-serious status, sex, age group, time from vaccination to symptom onset, exposure to known causes of EM/SJS/TEN, and vaccines administered. We used Empirical Bayesian data mining to detect vaccine-AE pairs reported more frequently than expected. RESULTS: Of 466,027 reports to VAERS during 1999–2017, we identified 984 reports of EM, 89 reports of SJS, 6 reports of SJS/TEN, and 7 reports of TEN. Few reports of EM (9%), and most reports of SJS (52%), SJS/TEN (100%), and TEN (100%) were serious. Overall, 55% of reports described males, 48% described children aged < 4 years; 58% of EM/SJS/TEN occurred ≤ 7 days after vaccination. Few reports (≤5%) described exposure to known causes of EM/SJS/TEN. Overall, childhood vaccines (e.g., combined measles, mumps, and rubella vaccine) were most commonly reported. We identified 6 deaths; 4 were exposed to medications associated with EM/SJS/TEN. EM after smallpox vaccine was reported disproportionately among people aged 19–49 years. CONCLUSIONS: EM/SJS/TEN were rarely reported after vaccination; data mining identified a known association between EM and smallpox vaccine. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect